Large-scale trial comparing topical and intravenous TXA efficacy in total knee arthroplasty .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2019;7(4):2 J Bone Joint Surg Am. 2018 Jun 20;100(12):1023-1029664 patients scheduled for total knee arthroplasty were randomized to either topical tranexamic acid or intravenous tranexamic acid. Patients were assessed for total blood loss, postoperative blood loss, and the incidence of transfusion. Results demonstrated that despite the statistically significantly lower total and postoperative blood loss in the intravenous group, there was no significant difference in the incidence of postoperative transfusion between groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
